Arkema SA
F:V1S
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Arkema SA
F:V1S
|
FR |
|
Minerva Surgical Inc
OTC:UTRS
|
US |
|
B
|
Benesse Holdings Inc
OTC:BSEFY
|
JP |
|
NETGEAR Inc
NASDAQ:NTGR
|
US |
|
Ariston Holding NV
F:E0E
|
IT |
|
C
|
Critical Elements Lithium Corp
XBER:F12
|
CA |
|
Y
|
Yum! Brands Inc
XMUN:TGR
|
US |
|
A
|
Applied Therapeutics Inc
F:2UV
|
US |
|
I
|
Incyte Corp
F:ICY
|
US |
|
T
|
Tanla Platforms Ltd
BSE:532790
|
IN |
|
U
|
Ur-Energy Inc
XMUN:U9T
|
US |
|
D
|
Danske Bank A/S
DUS:DSN
|
DK |
|
A
|
ASOS PLC
XBER:DYQ
|
UK |
|
Bradespar SA
F:FXMA
|
BR |
|
B
|
Bangkok Dusit Medical Services PCL
SET:BDMS
|
TH |
|
Checkpoint Therapeutics Inc
F:CZTA
|
US |
Wall St Price Targets
V1S Price Targets Summary
Arkema SA
According to Wall Street analysts, the average 1-year price target for V1S is 55.25 EUR with a low forecast of 43.06 EUR and a high forecast of 72.86 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is V1S's stock price target?
Price Target
55.25
EUR
According to Wall Street analysts, the average 1-year price target for V1S is 55.25 EUR with a low forecast of 43.06 EUR and a high forecast of 72.86 EUR.
What is the Revenue forecast for Arkema SA?
Projected CAGR
3%
Over the last 13 years, the compound annual growth rate for Revenue has been 3%. The projected CAGR for the next 7 years is 3%.
What is the Operating Income forecast for Arkema SA?
Projected CAGR
15%
Over the last 13 years, the compound annual growth rate for Operating Income has been -4%. The projected CAGR for the next 5 years is 15%.
What is the Net Income forecast for Arkema SA?
Projected CAGR
71%
Over the last 13 years, the compound annual growth rate for Net Income has been -12%. The projected CAGR for the next 5 years is 71%.
